MA51165A - Procédés de préparation de composés de (cyclopentyl[d]pyrimidin-4-yl)pipérazine - Google Patents

Procédés de préparation de composés de (cyclopentyl[d]pyrimidin-4-yl)pipérazine

Info

Publication number
MA51165A
MA51165A MA051165A MA51165A MA51165A MA 51165 A MA51165 A MA 51165A MA 051165 A MA051165 A MA 051165A MA 51165 A MA51165 A MA 51165A MA 51165 A MA51165 A MA 51165A
Authority
MA
Morocco
Prior art keywords
pyrimidin
cyclopentyl
processes
preparation
piperazine compounds
Prior art date
Application number
MA051165A
Other languages
English (en)
Inventor
Francis Gosselin
Chong Han
Hans Iding
Reinhard Reents
Scott Savage
Beat Wirz
Original Assignee
Hoffmann La Roche
Genentech Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Hoffmann La Roche, Genentech Inc filed Critical Hoffmann La Roche
Publication of MA51165A publication Critical patent/MA51165A/fr

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D239/00—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
    • C07D239/02—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings
    • C07D239/24—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members
    • C07D239/26—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D239/00—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
    • C07D239/02—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings
    • C07D239/24—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members
    • C07D239/28—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to ring carbon atoms
    • C07D239/32—One oxygen, sulfur or nitrogen atom
    • C07D239/42—One nitrogen atom
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A61K31/506—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim not condensed and containing further heterocyclic rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A61K31/517—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim ortho- or peri-condensed with carbocyclic ring systems, e.g. quinazoline, perimidine
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07B—GENERAL METHODS OF ORGANIC CHEMISTRY; APPARATUS THEREFOR
    • C07B57/00—Separation of optically-active compounds
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C253/00—Preparation of carboxylic acid nitriles
    • C07C253/30—Preparation of carboxylic acid nitriles by reactions not involving the formation of cyano groups
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C253/00—Preparation of carboxylic acid nitriles
    • C07C253/32—Separation; Purification; Stabilisation; Use of additives
    • C07C253/34—Separation; Purification
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C255/00—Carboxylic acid nitriles
    • C07C255/01—Carboxylic acid nitriles having cyano groups bound to acyclic carbon atoms
    • C07C255/19—Carboxylic acid nitriles having cyano groups bound to acyclic carbon atoms containing cyano groups and carboxyl groups, other than cyano groups, bound to the same saturated acyclic carbon skeleton
    • C07C255/22—Carboxylic acid nitriles having cyano groups bound to acyclic carbon atoms containing cyano groups and carboxyl groups, other than cyano groups, bound to the same saturated acyclic carbon skeleton containing cyano groups and at least two carboxyl groups bound to the carbon skeleton
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D239/00—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
    • C07D239/02—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings
    • C07D239/24—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members
    • C07D239/28—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to ring carbon atoms
    • C07D239/30—Halogen atoms or nitro radicals
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D239/00—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
    • C07D239/02—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings
    • C07D239/24—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members
    • C07D239/28—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to ring carbon atoms
    • C07D239/46—Two or more oxygen, sulphur or nitrogen atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D239/00—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
    • C07D239/02—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings
    • C07D239/24—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members
    • C07D239/28—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to ring carbon atoms
    • C07D239/46—Two or more oxygen, sulphur or nitrogen atoms
    • C07D239/52—Two oxygen atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D239/00—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
    • C07D239/02—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings
    • C07D239/24—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members
    • C07D239/28—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to ring carbon atoms
    • C07D239/46—Two or more oxygen, sulphur or nitrogen atoms
    • C07D239/52—Two oxygen atoms
    • C07D239/54—Two oxygen atoms as doubly bound oxygen atoms or as unsubstituted hydroxy radicals
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D239/00—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
    • C07D239/70—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings condensed with carbocyclic rings or ring systems
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D241/00—Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings
    • C07D241/02—Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings not condensed with other rings
    • C07D241/04—Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings not condensed with other rings having no double bonds between ring members or between ring members and non-ring members
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
    • C07D405/04—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/14—Hydrolases (3)
    • C12N9/78—Hydrolases (3) acting on carbon to nitrogen bonds other than peptide bonds (3.5)
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
    • C12P41/00—Processes using enzymes or microorganisms to separate optical isomers from a racemic mixture
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Y—ENZYMES
    • C12Y305/00—Hydrolases acting on carbon-nitrogen bonds, other than peptide bonds (3.5)
    • C12Y305/05—Hydrolases acting on carbon-nitrogen bonds, other than peptide bonds (3.5) in nitriles (3.5.5)
    • C12Y305/05001—Nitrilase (3.5.5.1)
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07B—GENERAL METHODS OF ORGANIC CHEMISTRY; APPARATUS THEREFOR
    • C07B2200/00—Indexing scheme relating to specific properties of organic compounds
    • C07B2200/07—Optical isomers
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02P—CLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
    • Y02P20/00—Technologies relating to chemical industry
    • Y02P20/50—Improvements relating to the production of bulk chemicals
    • Y02P20/55—Design of synthesis routes, e.g. reducing the use of auxiliary or protecting groups

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Zoology (AREA)
  • Engineering & Computer Science (AREA)
  • Wood Science & Technology (AREA)
  • General Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biochemistry (AREA)
  • General Engineering & Computer Science (AREA)
  • Medicinal Chemistry (AREA)
  • Biotechnology (AREA)
  • Microbiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Molecular Biology (AREA)
  • Biomedical Technology (AREA)
  • Analytical Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
MA051165A 2014-09-26 2015-09-25 Procédés de préparation de composés de (cyclopentyl[d]pyrimidin-4-yl)pipérazine MA51165A (fr)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US201462055893P 2014-09-26 2014-09-26

Publications (1)

Publication Number Publication Date
MA51165A true MA51165A (fr) 2020-10-21

Family

ID=54337353

Family Applications (1)

Application Number Title Priority Date Filing Date
MA051165A MA51165A (fr) 2014-09-26 2015-09-25 Procédés de préparation de composés de (cyclopentyl[d]pyrimidin-4-yl)pipérazine

Country Status (21)

Country Link
US (2) US10457648B2 (fr)
EP (2) EP3626710B1 (fr)
JP (3) JP6676043B2 (fr)
KR (1) KR102513869B1 (fr)
CN (2) CN112062727B (fr)
AR (2) AR102088A1 (fr)
AU (2) AU2015320510B2 (fr)
BR (1) BR112017005931B1 (fr)
CA (2) CA2962901C (fr)
ES (1) ES2749100T3 (fr)
HR (1) HRP20191943T1 (fr)
IL (2) IL251313B (fr)
MA (1) MA51165A (fr)
MX (2) MX368298B (fr)
MY (1) MY188699A (fr)
PL (1) PL3197875T3 (fr)
RU (2) RU2732404C2 (fr)
SG (2) SG11201702324QA (fr)
SI (1) SI3197875T1 (fr)
WO (1) WO2016049414A1 (fr)
ZA (1) ZA201702769B (fr)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
MX385726B (es) 2013-11-15 2025-03-18 Hoffmann La Roche Procesos para la preparación de compuestos de pirimidinilciclopentano.
BR112017005931B1 (pt) * 2014-09-26 2024-04-30 F. Hoffmann-La Roche Ag Processos para preparar um composto de ciclopentil[d]pirimidin-4-il) piperazina e composto de ciclopentil[d]pirimidin-4-il)piperazina
WO2021254920A1 (fr) * 2020-06-16 2021-12-23 F. Hoffmann-La Roche Ag Procédé de fabrication de composés de cyclopentylpyrimidine hydroxylée
CN112359078A (zh) * 2021-01-12 2021-02-12 凯莱英生命科学技术(天津)有限公司 异丁酸酯类化合物的手性拆分方法

Family Cites Families (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US1045764A (en) 1912-04-30 1912-11-26 Samuel Allen Guiberson Jr Casing-elevator.
GB9400889D0 (en) 1994-01-18 1994-03-16 Sandoz Ltd Novel compounds
DK1678182T3 (da) * 2003-10-28 2007-06-04 Schering Corp Fremgangsmåde til fremstilling af substituerede 5-amino-pyrazolo[4,3-E]-1,2,4-triazolo-[1,5-C]pyrimidiner
EP1807417A2 (fr) 2004-11-04 2007-07-18 Neurogen Corporation Dérivés hétéroaryles de pyrazolylméthyle
US7923557B2 (en) * 2004-11-10 2011-04-12 Synta Pharmaceuticals Corporation Process for preparing trisubstituted pyrimidine compounds
US8063050B2 (en) 2006-07-06 2011-11-22 Array Biopharma Inc. Hydroxylated and methoxylated pyrimidyl cyclopentanes as AKT protein kinase inhibitors
UA95641C2 (xx) 2006-07-06 2011-08-25 Эррей Биофарма Инк. Гідроксильовані піримідильні циклопентани як інгібітори акт протеїнкінази$гидроксилированные пиримидильные циклопентаны как ингибиторы акт протеинкиназы
WO2010002954A1 (fr) * 2008-07-02 2010-01-07 Wyeth Composés (2-aryl-7h-pyrrolo[2,3-d]pyrimidine-4-yl)morpholine, leur utilisation en tant qu’inhibiteurs de la mtor kinase et de la pi3 kinase, et leurs synthèses
US8703581B2 (en) 2011-06-15 2014-04-22 Applied Materials, Inc. Water soluble mask for substrate dicing by laser and plasma etch
DE102011080205A1 (de) 2011-08-01 2013-02-07 Bayerische Motoren Werke Aktiengesellschaft Verfahren zur Herstellung faserverstärkter keramischer Formkörper
WO2013068785A1 (fr) * 2011-11-09 2013-05-16 Actelion Pharmaceuticals Ltd Dérivés d'indanone et d'indanedione et analogues hétérocycliques
CA2873653A1 (fr) 2012-05-17 2013-11-21 Array Biopharma Inc. Procede de fabrication de composes cyclopentylpyrimidines hydroxylees
EP2850200A1 (fr) * 2012-05-17 2015-03-25 Genentech, Inc. Procédé de fabrication de composés de cyclopentapyrimidine hydroxylée et sels de ceux-ci
SI2861582T1 (sl) * 2012-05-17 2016-09-30 Array Biopharma, Inc. Postopek za izdelavo hidroksiliranih ciklopentilpirimidinskih spojin
MX350443B (es) * 2012-05-17 2017-09-06 Genentech Inc Proceso para hacer compuestos de aminoácidos.
MX385726B (es) 2013-11-15 2025-03-18 Hoffmann La Roche Procesos para la preparación de compuestos de pirimidinilciclopentano.
US9437599B2 (en) * 2014-08-12 2016-09-06 Kabushiki Kaisha Toshiba Nonvolatile semiconductor memory device and method of manufacturing the same
BR112017005931B1 (pt) * 2014-09-26 2024-04-30 F. Hoffmann-La Roche Ag Processos para preparar um composto de ciclopentil[d]pirimidin-4-il) piperazina e composto de ciclopentil[d]pirimidin-4-il)piperazina
KR102256602B1 (ko) 2017-12-14 2021-05-26 주식회사 엘지에너지솔루션 전압 측정 장치 및 방법

Also Published As

Publication number Publication date
MY188699A (en) 2021-12-23
EP3197875A1 (fr) 2017-08-02
NZ731073A (en) 2021-11-26
RU2017114035A3 (fr) 2019-04-22
SI3197875T1 (sl) 2019-12-31
AU2019253849A1 (en) 2019-11-14
RU2020101483A (ru) 2020-03-13
ES2749100T3 (es) 2020-03-19
MX368298B (es) 2019-09-27
JP6676043B2 (ja) 2020-04-08
CN107001287A (zh) 2017-08-01
HRP20191943T1 (hr) 2020-01-10
EP3626710B1 (fr) 2022-02-16
MX2017003791A (es) 2017-08-02
EP3626710A1 (fr) 2020-03-25
RU2017114035A (ru) 2018-10-26
CN112062727A (zh) 2020-12-11
RU2020101483A3 (fr) 2020-05-12
EP3197875B1 (fr) 2019-08-14
JP2017529371A (ja) 2017-10-05
KR102513869B1 (ko) 2023-03-23
JP6926254B2 (ja) 2021-08-25
MX2019011513A (es) 2019-11-18
US10457648B2 (en) 2019-10-29
PL3197875T3 (pl) 2020-03-31
BR112017005931B1 (pt) 2024-04-30
CA2962901C (fr) 2025-11-18
IL267756A (en) 2019-08-29
JP2021169535A (ja) 2021-10-28
IL251313B (en) 2019-08-29
AU2015320510B2 (en) 2019-11-21
CN107001287B (zh) 2020-09-04
CA2962901A1 (fr) 2016-03-31
AU2019253849B2 (en) 2020-07-09
SG10201806450SA (en) 2018-09-27
MX380718B (es) 2025-03-12
RU2712224C2 (ru) 2020-01-27
WO2016049414A1 (fr) 2016-03-31
SG11201702324QA (en) 2017-04-27
AU2015320510A1 (en) 2017-05-04
IL251313A0 (en) 2017-05-29
RU2732404C2 (ru) 2020-09-16
US20170247338A1 (en) 2017-08-31
US10870626B2 (en) 2020-12-22
US20200010428A1 (en) 2020-01-09
KR20170063809A (ko) 2017-06-08
JP2020059762A (ja) 2020-04-16
ZA201702769B (en) 2019-07-31
IL267756B (en) 2020-06-30
AR102088A1 (es) 2017-02-01
AR124856A2 (es) 2023-05-10
CN112062727B (zh) 2023-10-31
CA3190507A1 (fr) 2016-03-31
BR112017005931A2 (pt) 2017-12-19

Similar Documents

Publication Publication Date Title
MA49752A (fr) Procédés de préparation de composés de pyrrolidine
MA54253A (fr) Procédé de préparation de dérivés de 2-chloro-4-hétéroaryl-pyridimidines
IL253060A0 (en) Pyrimidine compounds are fused to treat hiv
MA40872A (fr) Méthodes pour la préparation de ribosides
IL264143B (en) Processes for preparing olaparib
HUE059158T2 (hu) Eljárás pridopidin elõállítására
MA52906A (fr) Procédé de préparation d'amg 416
SG11201704436YA (en) Five-coordinate bis-phenylphenoxy catalysts for the preparation of ethylene-based polymers
HUE058257T2 (hu) Eljárások oxatiazin-jellegû vegyületek elõállítására
HUE050974T2 (hu) Eljárás pirimidinszulfamid-származékok elõállítására
EP2977448A4 (fr) Procédé de préparation de chondrocytes
ZA201706795B (en) Process for the preparation of dicycloplatin
EP2970037A4 (fr) Procédés de préparation d'alkylfurannes
HUE060530T2 (hu) Eljárás halonitroaromás vegyületek katalitikus hidrogénezésére
IL248267A0 (en) A process for preparing converted cycloserines
IL268835B (en) A process for the preparation of 2-cyanoimidazole compounds
EP3500551A4 (fr) Procédé de préparation de biphényles substitués
IL278017B (en) A process for the cyclopropanation of olefins using n-methyl-n-nitroso compounds
EP3390368A4 (fr) Procédés de préparation de 5,6-dihydro-6-phénylbenzo[f]isoquinoléine-2-amine substituée
IL267756B (en) Process for preparing compound (cyclopentyl[d]pyrimidine-4-yl)piperazine
EP2910542A4 (fr) Procédé de préparation de méthylolalcanal
EP3265100A4 (fr) Procédés de préparation de fluorokétolides
EP3350154A4 (fr) Procédé amélioré de préparation de dichlorhydrate de trientine
IL275480A (en) A process for the preparation of pyrimidinyl-4-aminopyrazole compounds
FR3022234B1 (fr) Procede de preparation de nanofils de silicium.